MeBIO
Based on 1 Customer Validation
MeBIO is a potent AhR (aryl hydrocarbon receptor) agonist, with IC50 of 44 μM (GSK-3) and 55 μM (CDK1/cyclin B), respectively.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.0%
- CAS No.: 667463-95-8
- Formule: C17H12BrN3O2
- Masse moléculaire:370.20
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
|
GSK-3 44 μM (IC50) |
Cdk1/cyclin B 55 μM (IC50) |
Cdk5/p25 >100 μM (IC50) |
MeBIO (25 μM, 90 min) causes redistribution of AhR to the nucleus in wild-type Hepa-1 and ARNT mutant cells[2]. MeBIO (10 μM, 24 h) induces the aggregation of 5L cells in the G1 phase and increases the upregulation of p27 KIP1 expression in 5L cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:5 L cells and BP8 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Increased the expression of p27 KIP1 in 5L cells but not in BP8 cells
Chemical Information
-
CAS No. 667463-95-8
-
Appearance Solid
-
Masse moléculaire 370.20
-
Formule C17H12BrN3O2
-
Color Brown to reddish brown
-
SMILES
O=C1N(C)C2=C(C=CC(Br)=C2)/C1=C3NC4=C(C=CC=C4)C/3=N\O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
DMSO : 14.71 mg/mL (39.74 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (280 KB)
-
SDS (604 KB)
- English - EN (604 KB)
- Français - FR (604 KB)
- Deutsch - DE (604 KB)
- Norwegian - NO (604 KB)
- Español - ES (604 KB)
- Swedish - SV (604 KB)
- Italian - IT (604 KB)
- Korean - KR (604 KB)
- Portuguese - PT (604 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Meijer L, et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol. 2003 Dec;10(12):1255-66. [Content Brief]
[2]. Knockaert, et al. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 23.25 (2004): 4400-4412. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.7012 mL | 13.5062 mL | 27.0124 mL | 67.5311 mL |
| 5 mM | 0.5402 mL | 2.7012 mL | 5.4025 mL | 13.5062 mL | |
| 10 mM | 0.2701 mL | 1.3506 mL | 2.7012 mL | 6.7531 mL | |
| 15 mM | 0.1801 mL | 0.9004 mL | 1.8008 mL | 4.5021 mL | |
| 20 mM | 0.1351 mL | 0.6753 mL | 1.3506 mL | 3.3766 mL | |
| 25 mM | 0.1080 mL | 0.5402 mL | 1.0805 mL | 2.7012 mL | |
| 30 mM | 0.0900 mL | 0.4502 mL | 0.9004 mL | 2.2510 mL |